Literature DB >> 12154195

Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans.

Henning Langberg1, Jens L Olesen, Carsten Gemmer, Michael Kjaer.   

Abstract

Plasma interleukin-6 (IL-6) concentration has been shown to increase with exercise and various cell types and tissues have been suggested to be responsible for this increase. At present no studies have measured the interstitial concentration of IL-6 in skeletal muscle and connective tissue. The present study represents the first attempt to simultaneously measure IL-6 in plasma, skeletal muscle and peritendinous connective tissue in response to prolonged exercise. Six healthy well-trained volunteers completed a 36 km run (flat, 12 km h(-1)). IL-6 was measured before, 2 h post-exercise and 24 h, 48 h, 72 h and 96 h post-exercise in both the medial gastrocnemius muscle (not measured at rest due to risk of disabling the subsequent exercise, and 24 h and 72 h post-exercise) and the peritendinous tissue around the Achilles tendon using microdialysis catheters with a high molecular mass cut-off value (3000 kDa). The plasma concentration of IL-6 was measured simultaneously, and in addition every hour during the exercise, by enzyme-linked immunosorbent assay (ELISA). The plasma concentration of IL-6 was found to increase throughout the exercise, reaching peak values immediately after completion of the run (50-fold increase). Using the microdialysis technique, the interstitial concentration of IL-6 was found to increase dramatically from 0 +/- 0 pg ml(-1) to 3618 +/- 1239 pg ml(-1) in the peritendinous tissue in the hours following the exercise. The pattern of changes was similar in plasma and peritendinous tissue, although approximately 100-fold higher in the latter. For comparison the interstitial muscle concentration was found to be 465 +/- 176 pg ml(-1) when measured 2 h post-exercise and 223 +/- 113 pg ml(-1) and 198 +/- 96 pg ml(-1) 48 h and 96 h post-exercise, respectively. The present study demonstrates that the connective tissue around the human Achilles tendon produces significant amounts of IL-6 in response to prolonged physical activity, which might contribute to the exercise-induced increase in IL-6 found in plasma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12154195      PMCID: PMC2290459          DOI: 10.1113/jphysiol.2002.019141

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  26 in total

1.  Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running.

Authors:  R L Starkie; J Rolland; D J Angus; M J Anderson; M A Febbraio
Journal:  Am J Physiol Cell Physiol       Date:  2001-04       Impact factor: 4.249

Review 2.  Regulation of osteoclast activity.

Authors:  E M Greenfield; Y Bi; A Miyauchi
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

3.  Physical activity and plasma interleukin-6 in humans--effect of intensity of exercise.

Authors:  K Ostrowski; P Schjerling; B K Pedersen
Journal:  Eur J Appl Physiol       Date:  2000-12       Impact factor: 3.078

Review 4.  Epithelium-fibroblast interactions in response to airway inflammation.

Authors:  D Knight
Journal:  Immunol Cell Biol       Date:  2001-04       Impact factor: 5.126

Review 5.  Exercise and cytokines with particular focus on muscle-derived IL-6.

Authors:  B K Pedersen; A Steensberg; C Fischer; C Keller; K Ostrowski; P Schjerling
Journal:  Exerc Immunol Rev       Date:  2001       Impact factor: 6.308

6.  Plasma interleukin-6 during strenuous exercise: role of epinephrine.

Authors:  A Steensberg; A D Toft; P Schjerling; J Halkjaer-Kristensen; B K Pedersen
Journal:  Am J Physiol Cell Physiol       Date:  2001-09       Impact factor: 4.249

7.  Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans.

Authors:  R L Starkie; M J Arkinstall; I Koukoulas; J A Hawley; M A Febbraio
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

8.  Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.

Authors:  A Steensberg; G van Hall; T Osada; M Sacchetti; B Saltin; B Klarlund Pedersen
Journal:  J Physiol       Date:  2000-11-15       Impact factor: 5.182

9.  Relationship between gastro-intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men.

Authors:  A E Jeukendrup; K Vet-Joop; A Sturk; J H Stegen; J Senden; W H Saris; A J Wagenmakers
Journal:  Clin Sci (Lond)       Date:  2000-01       Impact factor: 6.124

Review 10.  Muscle-derived interleukin-6: possible biological effects.

Authors:  B K Pedersen; A Steensberg; P Schjerling
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

View more
  45 in total

Review 1.  Extracellular matrix adaptation of tendon and skeletal muscle to exercise.

Authors:  Michael Kjaer; Peter Magnusson; Michael Krogsgaard; Jens Boysen Møller; Jens Olesen; Katja Heinemeier; Mette Hansen; Bjarki Haraldsson; Satu Koskinen; Birgitte Esmarck; Henning Langberg
Journal:  J Anat       Date:  2006-04       Impact factor: 2.610

Review 2.  Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future.

Authors:  Christian Joukhadar; Markus Müller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 3.  Clinical features and pathophysiology of complex regional pain syndrome.

Authors:  Johan Marinus; G Lorimer Moseley; Frank Birklein; Ralf Baron; Christian Maihöfner; Wade S Kingery; Jacobus J van Hilten
Journal:  Lancet Neurol       Date:  2011-07       Impact factor: 44.182

4.  Targeting the NF-κB signaling pathway in chronic tendon disease.

Authors:  Adam C Abraham; Shivam A Shah; Mikhail Golman; Lee Song; Xiaoning Li; Iden Kurtaliaj; Moeed Akbar; Neal L Millar; Yousef Abu-Amer; Leesa M Galatz; Stavros Thomopoulos
Journal:  Sci Transl Med       Date:  2019-02-27       Impact factor: 17.956

Review 5.  Tendinopathy.

Authors:  Neal L Millar; Karin G Silbernagel; Kristian Thorborg; Paul D Kirwan; Leesa M Galatz; Geoffrey D Abrams; George A C Murrell; Iain B McInnes; Scott A Rodeo
Journal:  Nat Rev Dis Primers       Date:  2021-01-07       Impact factor: 52.329

6.  Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise.

Authors:  Benjamin F Miller; Jens L Olesen; Mette Hansen; Simon Døssing; Regina M Crameri; Rasmus J Welling; Henning Langberg; Allan Flyvbjerg; Michael Kjaer; John A Babraj; Kenneth Smith; Michael J Rennie
Journal:  J Physiol       Date:  2005-07-07       Impact factor: 5.182

7.  Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans.

Authors:  Mark A Febbraio; Adam Steensberg; Charlotte Keller; Rebecca L Starkie; Henning B Nielsen; Peter Krustrup; Peter Ott; Niels H Secher; Bente K Pedersen
Journal:  J Physiol       Date:  2003-04-17       Impact factor: 5.182

8.  Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans.

Authors:  Adam Steensberg; Christian P Fischer; Massimo Sacchetti; Charlotte Keller; Takuya Osada; Peter Schjerling; Gerrit van Hall; Mark A Febbraio; Bente Klarlund Pedersen
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

9.  No inflammatory gene-expression response to acute exercise in human Achilles tendinopathy.

Authors:  Jessica Pingel; Ulrich Fredberg; Lone Ramer Mikkelsen; Peter Schjerling; Katja Maria Heinemeier; Michael Kjaer; Adrian Harisson; Henning Langberg
Journal:  Eur J Appl Physiol       Date:  2013-04-16       Impact factor: 3.078

10.  Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization.

Authors:  Meghan Kelly; Marie-Soleil Gauthier; Asish K Saha; Neil B Ruderman
Journal:  Diabetes       Date:  2009-06-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.